Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
Chinese Patent Office
Argus Health
Cipla
Colorcon
Boehringer Ingelheim
Fish and Richardson
AstraZeneca

Generated: April 25, 2018

DrugPatentWatch Database Preview

PIPERACILLIN AND TAZOBACTAM Drug Profile

« Back to Dashboard

Which patents cover Piperacillin And Tazobactam, and what generic alternatives are available?

Piperacillin And Tazobactam is a drug marketed by Apollo Pharms Inc, Aurobindo Pharma Ltd, Hospira Inc, Istituto Bio Ita Spa, Mylan Labs Ltd, Sandoz, Wockhardt Bio Ag, and Sandoz Inc. and is included in thirteen NDAs.

The generic ingredient in PIPERACILLIN AND TAZOBACTAM is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Drug patent expirations by year for PIPERACILLIN AND TAZOBACTAM
Pharmacology for PIPERACILLIN AND TAZOBACTAM
Synonyms for PIPERACILLIN AND TAZOBACTAM
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2R)-2-(((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)-2-phenylacetyl)amino)-3,3-dimethyl-7-oxo-, sodium salt (1:1), (2S,5R,6R)-, mixt. with (2S,3S,5R)-3-methyl-7-ox
Piperacillin sodium and Tazobactam sodium
Piperacillin sodium mixture with tazobactam sodium
Piperacillin-tazobactam combination
Pipercillin sodium - tazobactam sodium
SCHEMBL18249818
Tazocin
TUPFOYXHAYOHIB-YCAIQWGJSA-M
Zobactin
ZOSYN IN PLASTIC CONTAINER
Zosyn injection

US Patents and Regulatory Information for PIPERACILLIN AND TAZOBACTAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Bio Ag PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 207146-001 Mar 17, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;IV (INFUSION) 203557-001 Oct 29, 2014 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apollo Pharms Inc PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 207847-001 Jan 13, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065458-003 Aug 15, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Baxter
Citi
Harvard Business School
Moodys
Healthtrust
Queensland Health
Mallinckrodt
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.